TY - JOUR AU - Simoens, Steven PY - 2011 DA - 2011/06/17 TI - Pricing and reimbursement of orphan drugs: the need for more transparency JO - Orphanet Journal of Rare Diseases SP - 42 VL - 6 IS - 1 AB - Pricing and reimbursement of orphan drugs are an issue of high priority for policy makers, legislators, health care professionals, industry leaders, academics and patients. This study aims to conduct a literature review to provide insight into the drivers of orphan drug pricing and reimbursement. SN - 1750-1172 UR - https://doi.org/10.1186/1750-1172-6-42 DO - 10.1186/1750-1172-6-42 ID - Simoens2011 ER -